about
Emerging roles for the non-canonical IKKs in cancerEmerging role of cystic fibrosis transmembrane conductance regulator - an epithelial chloride channel in gastrointestinal cancersEmerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancerOxidative stress responses and NRF2 in human leukaemiaNuclear factor kappa B role in inflammation associated gastrointestinal malignanciesSirtuins in hematological aging and malignancyAberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic targetAnticancer Activities of Protopanaxadiol- and Protopanaxatriol-Type Ginsenosides and Their MetabolitesExperimental evidence of ω-3 polyunsaturated fatty acid modulation of inflammatory cytokines and bioactive lipid mediators: their potential role in inflammatory, neurodegenerative, and neoplastic diseasesLysine deacetylase (KDAC) regulatory pathways: an alternative approach to selective modulationChemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 PathwaysTranscription Factors in the Cellular Response to Charged Particle ExposureMitochondrial Lon protease in human disease and aging: Including an etiologic classification of Lon-related diseases and disordersSilencing MARCH1 suppresses proliferation, migration and invasion of ovarian cancer SKOV3 cells via downregulation of NF-κB and Wnt/β-catenin pathwaysA multi-targeted approach to suppress tumor-promoting inflammationUncoupling of Pyrin-only protein 2 (POP2)-mediated dual regulation of NF-κB and the inflammasomeNF-kB mediated down-regulation of collagen synthesis upon HEMA (2-hydroxyethyl methacrylate) treatment of primary human gingival fibroblast/Streptococcus mutans co-cultured cellsPMS1077 sensitizes TNF-α induced apoptosis in human prostate cancer cells by blocking NF-κB signaling pathwayAnti-inflammatory effect of unsaturated fatty acids and Ergosta-7,22-dien-3-ol from Marthasterias glacialis: prevention of CHOP-mediated ER-stress and NF-κB activationPhospho-aspirin-2 (MDC-22) inhibits estrogen receptor positive breast cancer growth both in vitro and in vivo by a redox-dependent effectBlocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity.Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis.Calorie restriction decreases murine and human pancreatic tumor cell growth, nuclear factor-κB activation, and inflammation-related gene expression in an insulin-like growth factor-1-dependent manner.Differential cytokine regulation by NF-kappaB and AP-1 in Jurkat T-cells.Anticancer activity of Nelumbo nucifera stamen extract in human colon cancer HCT-116 cells in vitro.The lectin concanavalin-A signals MT1-MMP catalytic independent induction of COX-2 through an IKKgamma/NF-kappaB-dependent pathway.Dissecting carboxypeptidase E: properties, functions and pathophysiological roles in disease.Coactivator MYST1 regulates nuclear factor-κB and androgen receptor functions during proliferation of prostate cancer cells.Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression.Abrus agglutinin suppresses human hepatocellular carcinoma in vitro and in vivo by inducing caspase-mediated cell death.Resistin-induced stromal cell-derived factor-1 expression through Toll-like receptor 4 and activation of p38 MAPK/ NFκB signaling pathway in gastric cancer cells.NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population.Apurinic/apyrimidinic endonuclease/redox effector factor-1(APE/Ref-1): a unique target for the prevention and treatment of human melanoma.Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer.Overexpression of Chemokine (C-X-C) ligand 1 (CXCL1) associated with tumor progression and poor prognosis in hepatocellular carcinoma.Cross-talk between NFkB and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis.Ubiquitin-conjugating enzyme complex Uev1A-Ubc13 promotes breast cancer metastasis through nuclear factor-кB mediated matrix metalloproteinase-1 gene regulation.The role of n-3 polyunsaturated fatty acids in the prevention and treatment of breast cancerMelittin-glutathione S-transferase fusion protein exhibits anti-inflammatory properties and minimal toxicity.
P2860
Q24305225-71F132B7-059F-4BCB-A11E-44AF8F56F4B4Q26753851-6B348B9F-73EE-4BB1-9435-433217BD2F6FQ26778509-6BF027D8-08AE-43F9-8727-2D1A683FCD30Q26864239-782E1E81-1C80-41F4-A3EC-E0E8F3C30CC3Q26865584-BEB01B9B-3577-4AD5-A8C3-7B6FCD0C5E90Q26991467-10920F12-890B-411D-95DF-564E2D0DB860Q26995561-F07F1002-D7AA-46B7-9DF3-FFCDBFA70355Q27016631-78978263-F90F-44DA-9E9C-7FD2A1F98597Q27021694-8D6A8ED2-FC8B-444F-8628-F97286322056Q27021965-69662582-CDB0-4091-BD7B-B9B3EA4A08BCQ27315022-57DDE4FE-9755-49A4-9BB5-79F086ED894CQ28069717-EE5B2789-BEB9-479D-9BBC-D5FB2E64BF33Q28071866-7D343FBD-E608-462E-90CE-269B8A076F86Q28391161-D7DEAE29-EEA6-40F0-BDFF-CACA4DCD4748Q28393278-B825A825-8BFC-4E67-BC21-C80A3EEC7129Q28393834-7955D619-4B97-427A-A59E-7835303E4A07Q28393890-9D623392-183D-4C9C-9225-B2B521E5B8DDQ28486113-0C3C8498-BD18-4515-BCD0-37147F711423Q28539785-A8E636CE-F507-4A16-BFC4-6DA6E89A9DD0Q28544712-21A5FB31-AD7A-44A6-A076-B83B96E09A6EQ28553904-CD22415D-9091-4798-93D5-3839D58FA4BAQ30414471-2313B6E8-24CD-4AC4-BDBA-E36A10580CAFQ33424107-1465D408-BB06-4585-9CF8-87B48068DDA3Q33578477-2A7A2B81-9692-4B45-AF05-9677628A4872Q33589330-E78BCDB4-C18B-4AB5-ADC8-798BEF514431Q33598509-E0EDF46C-804C-4D74-9849-7D54E4A3057FQ33651146-C68A7A07-7D91-4B70-818D-806CFBB5B3F4Q33697577-40AA86E6-3AAF-4132-990B-AB00E0544A4AQ33701358-7CC6FA8D-7718-4A1E-A8BE-7B8E2793BE78Q33799921-2EE4D19F-A436-4757-B079-D6FAFA7C7352Q33861908-F2BDDF82-6633-40C6-BE79-EA7E2BF249DAQ33872957-7B1EDB48-9C80-441F-A4E1-67613CBB9DCDQ33955330-6825F09F-354A-4868-A799-8CDC09D3DD9BQ34104950-2B17914A-F56D-41FC-B7E9-00570D6A64E6Q34235551-6BE76DB6-E698-4A0C-8EC6-565554340B90Q34304058-91F81F38-EC0E-412F-8E57-6EDEFA983119Q34328449-CFA31CC7-E548-48D7-9028-1A7EE16104C8Q34468776-3DB66AB8-54B5-4857-8B56-C42A4A6C25E6Q34578129-4B7A1D46-D71B-48F8-AB14-1CF505673DD3Q34620675-7B30B42B-2391-451E-A813-C5892EACC08F
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
NF-kB in development and progression of human cancer.
@ast
NF-kB in development and progression of human cancer.
@en
type
label
NF-kB in development and progression of human cancer.
@ast
NF-kB in development and progression of human cancer.
@en
prefLabel
NF-kB in development and progression of human cancer.
@ast
NF-kB in development and progression of human cancer.
@en
P2093
P1433
P1476
NF-kB in development and progression of human cancer.
@en
P2093
David Llobet
Judit Pallares
Xavier Dolcet
Xavier Matias-Guiu
P2888
P304
P356
10.1007/S00428-005-1264-9
P577
2005-04-27T00:00:00Z